USB Drive of Trauma: Data in 2024

Researchers are exploring the potential of artificial intelligence (AI) and neurotechnology to deliver and monitor digital interventions for trauma, offering a scalable alternative to traditional, human-guided treatments. A recent study, published in Nature in December 2025, demonstrated the effectiveness of ANTIDOTE, an AI-guided system combining AI guidance and pupillometry to automatically deliver and monitor the Imagery Competing Task Intervention (ICTI).

The ICTI is a digital intervention previously delivered with human guidance, designed to reduce intrusive memories following psychological trauma. The study involved 100 healthy volunteers who were exposed to videos of traumatic events and then randomly assigned to either an intervention group or an active control group. Results showed that participants in the intervention group reported significantly fewer intrusive memories in the week following exposure to the videos.

According to the study, the AI guide successfully delivered the intervention as intended. Researchers found that pupil size – measured through pupillometry – tracked participant engagement and correlated with symptom reduction, suggesting it could serve as a potential biomarker for treatment effectiveness.

Trauma Prevalence and the Need for Scalable Solutions

The research highlights the widespread prevalence of trauma, with approximately 70% of people globally expected to experience a traumatic event in their lifetime. The study notes that in the United States, the lifetime prevalence of post-traumatic stress disorder (PTSD) has been estimated at 6%. While evidence-based digital treatments exist, their scalability is often limited by the need for human guidance.

Traditional interventions rely on human guides to provide tailored instructions and respond to individual internal states. However, this limits the number of people who can access these treatments. The development of AI-guided interventions, like ANTIDOTE, aims to overcome this limitation by providing a scalable and potentially more accessible solution.

How ANTIDOTE Works: AI Guidance and Pupillometry

ANTIDOTE utilizes generative AI to provide guidance throughout the ICTI process. The system also incorporates pupillometry, a technique that measures changes in pupil size, to assess participant engagement. Pupil size is believed to be an indicator of cognitive effort and emotional arousal, making it a potentially valuable biomarker for monitoring treatment response.

The study found a correlation between pupil size and symptom reduction, suggesting that the level of engagement tracked by pupillometry could predict the effectiveness of the intervention. This finding opens the door for further research into the use of neurotechnology as a tool for personalizing and optimizing digital mental health treatments.

Implications for Future Trauma Treatment

The findings suggest a promising path toward developing AI-guided digital interventions with significant scalability potential. This could be particularly beneficial for reaching individuals in underserved areas or those who face barriers to accessing traditional mental health care. The researchers believe that similar AI-driven approaches could be applied to other psychological interventions as well.

Christopher B. Colwell, MD, FACEP, of the Department of Emergency Medicine at San Francisco General Hospital and Trauma Center, UCSF School of Medicine, authored a 2024 Trauma Literature Update that further underscores the ongoing research in this field. A 2024 ESO Trauma Index utilized data from hospital admissions between January 1 and December 31, 2023, to analyze real-world trauma cases.

Further research is needed to validate these findings in larger and more diverse populations. However, the initial results of the ANTIDOTE study offer a compelling glimpse into the future of trauma treatment, where AI and neurotechnology could play a crucial role in delivering accessible and effective care.